BHVN
Biohaven Pharmaceutical Holding Company Ltd

3,306
Mkt Cap
$1.37B
Volume
2.62M
52W High
$44.28
52W Low
$7.48
PE Ratio
-1.40
BHVN Fundamentals
Price
$11.43
Prev Close
$10.60
Open
$10.85
50D MA
$12.74
Beta
1.70
Avg. Volume
6.72M
EPS (Annual)
-$9.28
P/B
-65.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology...
PR Newswire·9h ago
News Placeholder
More News
News Placeholder
Biohaven (NYSE:BHVN) Stock Price Down 5% - What's Next?
Biohaven (NYSE:BHVN) Trading Down 5% - What's Next...
MarketBeat·2d ago
News Placeholder
Norges Bank Makes New $12.74 Million Investment in Biohaven Ltd. $BHVN
Norges Bank acquired a new stake in Biohaven Ltd. (NYSE:BHVN - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm...
MarketBeat·2d ago
News Placeholder
Norges Bank Makes New $12.74 Million Investment in Biohaven Ltd. $BHVN
Norges Bank acquired a new stake in Biohaven Ltd. (NYSE:BHVN - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm...
MarketBeat·2d ago
News Placeholder
Biohaven (NYSE:BHVN) Trading Up 8.8% - Still a Buy?
Biohaven (NYSE:BHVN) Stock Price Up 8.8% - What's Next...
MarketBeat·3d ago
News Placeholder
FY2025 EPS Estimates for Biohaven Increased by HC Wainwright
Biohaven Ltd. (NYSE:BHVN - Free Report) - Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Biohaven in a research note issued on Wednesday...
MarketBeat·4d ago
News Placeholder
FY2025 EPS Estimates for Biohaven Increased by HC Wainwright
Biohaven Ltd. (NYSE:BHVN - Free Report) - Stock analysts at HC Wainwright lifted their FY2025 earnings per share (EPS) estimates for shares of Biohaven in a research note issued on Wednesday...
MarketBeat·4d ago
News Placeholder
Biohaven Ltd. $BHVN Position Lowered by Panagora Asset Management Inc.
Panagora Asset Management Inc. trimmed its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 70.6% in the second quarter, according to its most recent disclosure with the SEC. The institutional...
MarketBeat·4d ago
News Placeholder
Biohaven (NYSE:BHVN) Shares Gap Down - Time to Sell?
Biohaven (NYSE:BHVN) Shares Gap Down - What's Next...
MarketBeat·7d ago
News Placeholder
How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 127.52%
The average of price targets set by Wall Street analysts indicates a potential upside of 127.5% in Biohaven Ltd. (BHVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·7d ago

Latest BHVN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.